Shuai Yang
College of Life Science and Technology, Huazhong University of Science and Technology. 430074, China.
Heliyon. 2023 Jul 5;9(7):e18019. doi: 10.1016/j.heliyon.2023.e18019. eCollection 2023 Jul.
Phototherapy has attracted widespread attention for cancer treatment due to its noninvasiveness and high selectivity. However, severe hypoxia, overexpressed glutathione and high levels of hydrogen peroxide (HO) of tumor microenvironment limit the antitumor efficiency of phototherapy. Herein, inspired by the specific response of nanozymes to the tumor microenvironment, a simple and versatile nanozyme-mediated synergistic dual phototherapy nanoplatform is constructed. In this study, tin ferrite (SnFeO, SFO) nanozyme as a photosensitizer was surface modified with polydopamine (denoted as P-SFO) and incorporated into poly(l-lactide) to fabricate an antitumor scaffold fabricated by selective laser sintering. On one hand, SFO nanozyme could act as a photoabsorber to convert light energy into heat for photothermal therapy (PTT). On the other hand, it played a role of photosensitizer in transferring the photon energy to generate reactive oxygen species (ROS) for photodynamic therapy (PDT). Importantly, its multivalent metal ions redox couples would decompose HO into O for enhancing O-dependent PDT and consume glutathione to relieve antioxidant capability of the tumors. Besides, polydopamine as a photothermal conversion agent further enhanced the photothermal performance of SFO. The results revealed the PLLA/P-SFO scaffold possessed a photothermal conversion efficiency of 43.52% for PTT and a high ROS generation capacity of highly toxic ·O and ·OH for PDT. Consequently, the scaffold displayed a prominent phototherapeutic effect with antitumor rate of 96.3%. In addition, the PLLA/P-SFO scaffolds possessed good biocompatibility for cell growth. These advantages endow PLLA/P-SFO scaffold with extensive applications in biomedical fields and opened up new avenue towards nanozyme-mediated synergistic phototherapy.
光疗法因其非侵入性和高选择性在癌症治疗中受到广泛关注。然而,肿瘤微环境中的严重缺氧、谷胱甘肽过表达以及高浓度的过氧化氢(HO)限制了光疗法的抗肿瘤效率。在此,受纳米酶对肿瘤微环境的特异性响应启发,构建了一种简单且通用的纳米酶介导的协同双光疗法纳米平台。在本研究中,作为光敏剂的锡铁氧体(SnFeO,SFO)纳米酶用聚多巴胺进行表面修饰(记为P-SFO),并掺入聚(L-丙交酯)中,通过选择性激光烧结制备抗肿瘤支架。一方面,SFO纳米酶可作为光吸收剂将光能转化为热量用于光热疗法(PTT)。另一方面,它在传递光子能量以产生活性氧(ROS)用于光动力疗法(PDT)中起光敏剂的作用。重要的是,其多价金属离子氧化还原对会将HO分解为O以增强O依赖的PDT,并消耗谷胱甘肽以减轻肿瘤的抗氧化能力。此外,聚多巴胺作为光热转换剂进一步增强了SFO的光热性能。结果表明,PLLA/P-SFO支架用于PTT的光热转换效率为43.52%,用于PDT产生高毒性·O和·OH的ROS生成能力高。因此,该支架显示出显著的光疗效果,抗肿瘤率为96.3%。此外,PLLA/P-SFO支架对细胞生长具有良好的生物相容性。这些优点使PLLA/P-SFO支架在生物医学领域具有广泛应用,并为纳米酶介导的协同光疗法开辟了新途径。